![Franklin Berger](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Franklin Berger
Director/Board Member at
ATEA PHARMACEUTICALS, INC.
Net worth: 7 M $ as of 2026-05-30
Profile
Franklin M.
Berger founded NEMO Fund, Inc. in 2007, where he worked as Senior Manager-Portfolio from 2007 to 2008 and FMB Research in 2005, where he is working as Managing Director from 2005.
Mr. Berger also currently works at Satellos Bioscience, Inc., as Director from 2023, BELLUS Health, Inc., as Independent Director from 2010, Atea Pharmaceuticals, Inc., as Lead Independent Director from 2019, and various other companies.
Mr. Berger also formerly worked at Proteostasis Therapeutics, Inc., as Chairman from 2019 to 2020, Emisphere Technologies, Inc., as Director in 2009, Lineage Cell Therapeutics, Inc., as Independent Director in 2014, and various other companies.
Mr. Berger received his undergraduate degree in 1971 and graduate degree in 1972 from The Johns Hopkins University and Masters Business Admin degree in 1975 from Harvard Business School.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-02-08 | 681,333 ( 3.27% ) | 5 M $ | 2026-05-30 | |
| 2026-04-23 | 536,097 ( 0.67% ) | 3 M $ | 2026-05-30 |
Franklin Berger active positions
| Companies | Position | Start |
|---|---|---|
| BELLUS HEALTH | Director/Board Member | 2010-04-30 |
| ATEA PHARMACEUTICALS, INC. | Director/Board Member | 2019-08-31 |
| SATELLOS BIOSCIENCE INC. | Director/Board Member | 2023-06-28 |
Qiming US Ventures Management, LLC
 Qiming US Ventures Management, LLC Investment ManagersFinance Qiming Venture Partners invests in companies located in the United States and Europe. The firm focuses on the healthcare sector. It participates in early stage capital transactions. | Consultant / Advisor | 2018-12-31 |
Walking Fish Therapeutics, Inc.
 Walking Fish Therapeutics, Inc. BiotechnologyHealth Technology Develops cell-based therapeutics to treat diseases | Director/Board Member | - |
FMB Research
 FMB Research MiscellaneousMiscellaneous Operates as a non-classified establishment | Chief Executive Officer | 2005-05-31 |
Former positions of Franklin Berger
| Companies | Position | End |
|---|---|---|
| KEZAR LIFE SCIENCES, INC. | Director/Board Member | 2026-05-10 |
| ESSA PHARMA INC. | Director/Board Member | 2025-10-08 |
| ATRECA, INC. | Director/Board Member | 2024-05-12 |
| ░░░░ ░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░ ░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
Training of Franklin Berger
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
59
1st degree connections
41
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 41 |
|---|---|
Emisphere Technologies, Inc.
 Emisphere Technologies, Inc. Pharmaceuticals: MajorHealth Technology Operates as a commercial stage pharmaceutical and drug delivery company | Health Technology |
Lineage Cell Therapeutics, Inc.
 Lineage Cell Therapeutics, Inc. BiotechnologyHealth Technology Engages in research and development of therapeutic products for retinal & neurological diseases and disorders and oncology | Health Technology |
iTherX Pharmaceuticals, Inc.
 iTherX Pharmaceuticals, Inc. Medical DistributorsDistribution Services Engages in the discovery and development of drugs and therapies | Distribution Services |
VaxGen, Inc.
 VaxGen, Inc. BiotechnologyHealth Technology Develops, manufactures and commercializes biologic products | Health Technology |
Seagen, Inc.
 Seagen, Inc. Pharmaceuticals: MajorHealth Technology Develops monoclonal antibody-based therapeutic products for treatment of cancer and immunologic diseases | Health Technology |
BELLUS Health, Inc.
 BELLUS Health, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops therapeutics for the treatment of refractory chronic disease | Health Technology |
Isotechnika, Inc.
 Isotechnika, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops immunosuppressive therapeutic drugs | Health Technology |
JPMorgan Securities LLC
 JPMorgan Securities LLC Investment Banks/BrokersFinance Provides corporate, investment banking, consumer and commercial banking, asset management, payment & security solutions | Finance |
Five Prime Therapeutics, Inc.
 Five Prime Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops protein therapeutics for cancer and inflammatory diseases | Health Technology |
Tocagen, Inc.
 Tocagen, Inc. BiotechnologyHealth Technology Develops biopharmaceutical drugs | Health Technology |
Atreca, Inc.
 Atreca, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops novel antibody-based immune therapeutics to treat a range of solid tumor cancers | Health Technology |
Asterias Biotherapeutics, Inc.
 Asterias Biotherapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which develops and commercializes regenerative medicine for neurology and oncology applications | Health Technology |
Alzheon, Inc.
 Alzheon, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that develops drugs for neurodegenerative disorders | Health Technology |
Atea Pharmaceuticals, Inc.
 Atea Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes antiviral therapeutics | Health Technology |
Smith Barney Asset Management
 Smith Barney Asset Management Investment ManagersFinance Provides investment services | Finance |
Sectoral Asset Management, Inc.
 Sectoral Asset Management, Inc. Investment ManagersFinance Sectoral aims to achieve superior returns for their investors by concentrating on primary research of company fundamentals and in-depth due diligence on companies to assess their scientific, business, financial and ESG aspects. The firm offers four Healthcare strategies: Global Healthcare, Emerging Healthcare, Small & Mid-Cap Healthcare & Biotech. They employ a bottom-up investment approach that can be categorized as Growth at a Reasonable Price (GARP). | Finance |
Josephthal & Co (Broker)
 Josephthal & Co (Broker) Investment Banks/BrokersFinance Brokerage firm | Finance |
The Johns Hopkins University
 The Johns Hopkins University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ViroChem Pharma, Inc.
 ViroChem Pharma, Inc. Pharmaceuticals: MajorHealth Technology Provides antiviral drug research and development services | Health Technology |
HealthShares, Inc.
 HealthShares, Inc. Investment Trusts/Mutual FundsMiscellaneous Exchange Traded Fund | Miscellaneous |
Thallion Pharmaceuticals, Inc.
 Thallion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops new pharmaceutical products | Health Technology |
CellCarta Biosciences, Inc.
 CellCarta Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as specialty contract research laboratory | Commercial Services |
Proteostasis Therapeutics, Inc.
 Proteostasis Therapeutics, Inc. BiotechnologyHealth Technology Develops disease-modifying therapeutics for orphan and neurodegenerative diseases | Health Technology |
The Genetics Co., Inc.
 The Genetics Co., Inc. Medical/Nursing ServicesHealth Services Researchs, develops and commercializes products for the health industry | Health Services |
Immune Design Corp.
 Immune Design Corp. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical and clinical-stage immunotherapy company | Health Technology |
Salomon Smith Barney, Inc.
 Salomon Smith Barney, Inc. Investment Banks/BrokersFinance Provides investment banking services | Finance |
Isotechnika Pharma, Inc.
 Isotechnika Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company, which focuses on discovery and development of immunomodulating therapeutics | Health Technology |
Episcopal Relief & Development Corp.
 Episcopal Relief & Development Corp. Miscellaneous Commercial ServicesCommercial Services Operates as a relief and development agency | Commercial Services |
NEMO Fund, Inc. | |
ESSA Pharma, Inc.
 ESSA Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops small molecule drugs | Health Technology |
Aurinia Pharmaceuticals, Inc.
 Aurinia Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company, which focuses on discovery and development of immunomodulating therapeutics | Health Technology |
Harvard Business School
 Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kezar Life Sciences, Inc.
 Kezar Life Sciences, Inc. BiotechnologyHealth Technology Discovers and develops therapies targeting protein homeostasis | Health Technology |
FMB Research
FMB Research MiscellaneousMiscellaneous Operates as a non-classified establishment | Miscellaneous |
Caprion Proteomics, Inc.
 Caprion Proteomics, Inc. Medical SpecialtiesHealth Technology Provides proteomics and immune monitoring services to the pharmaceutical and biotechnology industry | Health Technology |
Applied Therapeutics, Inc.
 Applied Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops transformative drugs and technologies for debilitating diseases | Health Technology |
Rain Oncology, Inc.
 Rain Oncology, Inc. BiotechnologyHealth Technology Operates as a clinical-stage precision oncology company that develops therapeutics for cancer patients | Health Technology |
Qiming US Ventures Management, LLC
Qiming US Ventures Management, LLC Investment ManagersFinance Qiming Venture Partners invests in companies located in the United States and Europe. The firm focuses on the healthcare sector. It participates in early stage capital transactions. | Finance |
Walking Fish Therapeutics, Inc.
Walking Fish Therapeutics, Inc. BiotechnologyHealth Technology Develops cell-based therapeutics to treat diseases | Health Technology |
Brookline Capital Acquisition Corp.
 Brookline Capital Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
Satellos Bioscience, Inc.
 Satellos Bioscience, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company, which is focused on the identification, development and commercialization of drug candidates | Health Technology |
- Stock Market
- Insiders
- Franklin Berger
